TABLE 7.

Summary of all serum parameters.

	Control					Vibration
	Contrast	% change	p-value	95% lower bound	95% upper bound	Contrast	% change	p-value	95% lower bound	95% upper bound	p-value group*month	p-value month
PINP (ug/L)											p = 0.3254	p = 0.509
Month 6 vs. Baseline	0.23	0.41	1.00	−2.34	2.79	−0.76	−1.36	1.00	−3.80	2.27
Month 12 vs. Baseline	−0.43	−0.76	1.00	−4.07	3.22	1.05	1.88	1.00	−2.64	4.74
Month 18 vs. Baseline	−0.61	−1.10	1.00	−5.11	3.88	−2.03	−3.61	1.00	−6.27	2.21
CTX (pmol/L)											p = 0.0155	p < 0.001
Month 6 vs. Baseline	223.34	5.39	0.39	−95.26	541.94	169.85	3.92	1.00	−161.59	501.28
Month 12 vs. Baseline	25.42	0.61	1.00	−326.68	377.52	506.29	11.68	0.00	136.70	875.88
Month 18 vs. Baseline	304.45	7.35	021	−77.31	686.22	797.43	18.40	0.00	361.07	1233.79
BAP (ug/L)											p = 0.3818	p < 0.001
Month 6 vs. Baseline	1.29	10.57	0.00	0.70	1.89	1.21	10.31	0.00	0.53	1.88
Month 12 vs. Baseline	2.37	19.33	0.00	1.56	3.17	2.51	21.41	0.00	1.71	3.31
Month 18 vs. Baseline	3.48	28.45	0.00	2.47	4.50	2.87	24.47	0.00	1.95	3.78
Sclerostin (ng/mL)											p = 0.0881	p = 0.772
Month 6 vs. Baseline	0.01	1.96	0.89	−0.01	0.04	−0.01	−1.62	1.00	−0.03	0.02
Month 12 vs. Baseline	0.00	−0.36	1.00	−0.03	0.02	0.00	0.65	1.00	−0.02	0.03
Month 18 vs. Baseline	0.01	1.11	1.00	−0.02	0.03	0.00	0.73	1.00	−0.02	0.03